📊 CHMX Key Takeaways
Investment Thesis
NEXT-ChemX is in severe financial distress with negative stockholders' equity of -3.8M, insolvency risk, and deteriorating operations. Revenue collapsed 90.3% YoY to just 500K while the company burns cash at an unsustainable rate with -537.1K free cash flow and critically low liquidity (0.14x current ratio). The company is operationally unprofitable with -162.9% operating margin and faces imminent solvency concerns absent dramatic operational turnaround or capital infusion.
CHMX Strengths
- High gross margin of 98.1% suggests strong unit economics if revenue can be recovered
- Minimal capital expenditure requirement indicates low ongoing investment needs
- Low absolute debt burden at 845K in long-term debt provides some flexibility
CHMX Risks
- Negative equity of -3.8M indicates technical insolvency and potential going concern issues
- Severe revenue decline of 90.3% YoY suggests fundamental business model deterioration or loss of major customers
- Critical liquidity crisis with only 22K cash and 0.14x current ratio creates immediate runway concerns
- Negative free cash flow of -537.1K at current burn rate exhausts remaining cash in weeks
- Operating losses of -814.6K with no clear path to profitability in near term
- No insider buying activity in 90 days suggests lack of confidence from management
Key Metrics to Watch
- Monthly revenue run rate and customer retention to assess stabilization
- Cash burn rate and runway to next funding requirement
- Operating cash flow trend and path to cash flow breakeven
- Whether company obtains capital infusion or debt restructuring to address negative equity
CHMX Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CHMX Profitability Ratios
CHMX vs Default Sector
How NEXT-ChemX Corporation. compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CHMX Balance Sheet & Liquidity
CHMX 5-Year Financial Trend
5-Year Trend Summary: NEXT-ChemX Corporation.'s revenue has remained relatively flat over the 5-year period, with a 5% decline. The most recent EPS of $-0.09 indicates the company is currently unprofitable.
CHMX Growth Metrics (YoY)
CHMX Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2023 | $500.0K | -$387.9K | $-0.01 |
| Q3 2020 | $942 | -$16.8K | N/A |
| Q2 2020 | $5.0K | -$41.6K | N/A |
| Q3 2019 | $942 | -$9.2K | N/A |
| Q2 2019 | $5.0K | -$14.0K | N/A |
| Q3 2017 | $1.5K | -$16.6K | N/A |
| Q2 2017 | $1.5K | -$10.2K | N/A |
| Q1 2017 | $1.5K | -$4.2K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CHMX Capital Allocation
CHMX SEC Filings
Access official SEC EDGAR filings for NEXT-ChemX Corporation. (CIK: 0001657045)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CHMX
What is the AI rating for CHMX?
NEXT-ChemX Corporation. (CHMX) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CHMX's key strengths?
High gross margin of 98.1% suggests strong unit economics if revenue can be recovered. Minimal capital expenditure requirement indicates low ongoing investment needs.
What are the risks of investing in CHMX?
Negative equity of -3.8M indicates technical insolvency and potential going concern issues. Severe revenue decline of 90.3% YoY suggests fundamental business model deterioration or loss of major customers.
What is CHMX's revenue and growth?
NEXT-ChemX Corporation. reported revenue of $500.0K.
Does CHMX pay dividends?
NEXT-ChemX Corporation. does not currently pay dividends.
Where can I find CHMX SEC filings?
Official SEC filings for NEXT-ChemX Corporation. (CIK: 0001657045) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CHMX's EPS?
NEXT-ChemX Corporation. has a diluted EPS of $-0.03.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.